AKR1C3 and posterior cortical atrophy: To further evaluate whether AKR1C3 was related to enzalutamide sensitivity in PCa cells, the activity of LNCaP cells was significantly inhibited after treatment with 20 um enzalutamide for 48 h (Figure 10D).